A year in review (2022): Modulators and COVID19, the story goes on….
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society（2023）
Abstract
In this review we have aimed to cover some of the highlights of the cystic fibrosis (CF) literature in 2022, which again has been dominated by the SARS-CoV-2 (COVID-19) pandemic and modulator therapy. We have also explored other themes, such as novel findings in relation to pulmonary exacerbations, early lung disease and emerging areas for people with CF (pwCF).
MoreTranslated text
Key words
covid19,modulators
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined